Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells

Li,Xiaojiang; Ma,Shaojun; Yang,Peiying; Sun,Binxu; Zhang,Ying; Sun,Yuehong; Hao,Meimei; Mou,Ruiyu; Jia,Yingjie

doi:10.3892/ol.2018.9488

Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells

Authors:
- Xiaojiang Li
- Shaojun Ma
- Peiying Yang
- Binxu Sun
- Ying Zhang
- Yuehong Sun
- Meimei Hao
- Ruiyu Mou
- Yingjie Jia
View Affiliations

Affiliations: Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China, Department of Interventional Vascular, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China, Department of Radiochemotherapy, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Cangzhou, Hebei 061899, P.R. China, Department of Oncology, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi 710003, P.R. China
Published online on: September 24, 2018 https://doi.org/10.3892/ol.2018.9488
Pages: 6756-6762

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin is a key polyphenolic curcuminoid extracted from the root of turmeric rhizome Curcuma longa Linn, which is a frequently used Chinese herb for the treatment of cancer. The aim of the present study was to investigate the mechanism of the inhibitory effects of curcumin on nude mice with lung cancer A549 cell subsets side population (SP) and non‑SP (NSP) cells. BALB/c mice were subcutaneously injected with the tumor cells of A549 SP or NSP subsets consisting of 1x109 cells/l (0.2 ml in total). After 16 days of inoculation with A549, the mice were intraperitoneally injected with curcumin (100 mg/kg, 0.2 ml) once every other day, eight times in total. A series of assays were performed to detect the effects of curcumin on: i) Tumor weight and size; ii) Notch and hypoxia inducible factor 1 (HIF‑1) mRNA expression by quantitative polymerase chain reaction; and iii) vascular endothelial growth factor (VEGF) and nuclear factor‑κB (NF‑κB) by immunohistochemistry. It was determined that curcumin decreased the tumor weight and size, downregulated the expression of Notch and HIF‑1 mRNA and suppressed the VEGF and NF‑κB expression. These results indicated that curcumin inhibited lung cancer growth through the regulation of angiogenesis mediated by VEGF signaling.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
2	Islami F, Torre LA and Jemal A: Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 44:327–338. 2015.
3	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
4	Lam WK, White NW and Chan-Yeung MM: Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis. 8:1045–1057. 2004.PubMed/NCBI
5	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
6	Peng H, Ma M and Han B: Survival analysis of 1,742 patients with stage IV non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 14:362–636. 2011.(In Chinese). PubMed/NCBI
7	Ming X, Feng Y, Yang C, Wang W, Wang P and Deng J: Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update. Medicine (Baltimore). 95:e50512016. View Article : Google Scholar : PubMed/NCBI
8	Ho MM, Ng AV, Lam S and Hung JY: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007. View Article : Google Scholar : PubMed/NCBI
9	Hou GX, Liu PP, Zhang S, Yang M, Liao J, Yang J, Hu Y, Jiang WQ, Wen S and Huang P: Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis. Cell Death Dis. 9:892018. View Article : Google Scholar : PubMed/NCBI
10	Akunuru S, Palumbo J, Zhai QJ and Zheng Y: Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity. PLoS One. 6:e169512011. View Article : Google Scholar : PubMed/NCBI
11	Qiu C, Zhang T, Zhang W, Zhou L, Yu B, Wang W, Yang Z, Liu Z, Zou P and Liang G: Licochalcone A Inhibits the proliferation of human lung cancer cell lines A549 and H460 by Inducing G2/M cell cycle arrest and ER stress. Int J Mol Sci. 18:pii: E17612017. View Article : Google Scholar
12	Feng H, Lu JJ, Wang Y, Pei L and Chen X: Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells. Cell Adh Migr. 11:464–475. 2017. View Article : Google Scholar : PubMed/NCBI
13	Li B, Shi C, Li B, Zhao JM and Wang L: The effects of curcumin on HCT-116 cells proliferation and apoptosis via the miR-491/PEG10 pathway. J Cell Biochem. 119:3091–3098. 2018. View Article : Google Scholar : PubMed/NCBI
14	Wang YL, Ju B, Zhang YZ, Yin HL, Liu YJ, Wang SS, Zeng ZL, Yang XP, Wang HT and Li JF: Protective effect of curcumin against oxidative stress-induced injury in rats with Parkinson's disease through the Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 43:2226–2241. 2017. View Article : Google Scholar : PubMed/NCBI
15	Zhang M, Tang J, Li Y, Xie Y, Shan H, Chen M, Zhang J and Yang X, Zhang Q and Yang X: Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved. Chem Biol Interact. 277:168–175. 2017. View Article : Google Scholar : PubMed/NCBI
16	Zhao Z, Yang Y, Liu W and Li Z: T59, a new compound reconstructed from curcumin, induces cell Apoptosis through reactive oxygen species activation in human lung cancer cells. Molecules. 23:pii: E12512018. View Article : Google Scholar
17	Shimada K, Ushijima K, Suzuki C, Horiguchi M, Ando H, Akita T, Shimamura M, Fujii J, Yamashita C and Fujimura A: Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice. Cancer Chemother Pharmacol. 82:265–273. 2018. View Article : Google Scholar : PubMed/NCBI
18	Li Y, Zhang S, Geng JX and Hu XY: Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev. 14:4599–602. 2013. View Article : Google Scholar : PubMed/NCBI
19	Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A and Yu Y: Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549. Oncol Lett. 14:2775–2782. 2017. View Article : Google Scholar : PubMed/NCBI
20	Hollands C: The Animals (scientific procedures) Act 1986. Lancet. 8497:32–33. 1986. View Article : Google Scholar
21	Wo XD, H XQ and G CX: Long term toxicity test of curcumin. J Zhejiang College TCM. 24:61–65. 2000.(In Chinese).
22	Zhuang HW, Mo TT, Hou WJ, Xiong GX, Zhu XL, Fu QL and Wen WP: Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma. Oncol Rep. 30:57–63. 2013. View Article : Google Scholar : PubMed/NCBI
23	Yu L, Garg HG, Li B, Linhardt RJ and Hales CA: Antitumor effect of butanoylated heparin with low anticoagulant activity on lung cancer growth in mice and rats. Curr Cancer Drug Targets. 10:229–241. 2010. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Dela Cruz CS, Tanoue LT and Matthay RA: Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
26	Hopwood P and Stephens RJ: Symptoms at presentation for treatment in patients with lung cancer: Implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 71:633–636. 1995. View Article : Google Scholar : PubMed/NCBI
27	Goodell MA, Brose K, Paradis G, Conner AS and Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
28	Hadnagy A, Gaboury L, Beaulieu R and Balicki D: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
29	Sales KM, Winslet MC and Seifalian AM: Stem cells and cancer: An overview. Stem Cell Rev. 3:249–255. 2007. View Article : Google Scholar : PubMed/NCBI
30	Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG and Cowan K: The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res. 8:22–28. 2002.PubMed/NCBI
31	Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
32	Ferrara N: The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat. 36:127–137. 1995. View Article : Google Scholar : PubMed/NCBI
33	Hicklin DJ and Ellis LM: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar : PubMed/NCBI
34	Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S, Chen Y and Wu K: Notch signaling and EMT in non-small cell lung cancer: Biological significance and therapeutic application. J Hematol Oncol. 7:872014. View Article : Google Scholar : PubMed/NCBI
35	Allen TD, Rodriguez EM, Jones KD and Bishop JM: Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
36	Guo L, Zhang T, Xiong Y and Yang Y: Roles of NOTCH1 as a therapeutic target and a biomarker for lung cancer: Controversies and perspectives. Dis Markers. 2015:5205902015. View Article : Google Scholar : PubMed/NCBI
37	Karin M and Greten FR: NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI